Anand Ananthakrishnan | Senior Director, Drug Safety and Pharmacovigilance
Blueprint Medicines

With over 20 years of experience in the pharmacovigilance domain, Anand Ananthakrishnan currently holds the position of Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines, a biotechnology firm located in Cambridge, Massachusetts. Before joining Blueprint Medicines, he served as the Director of PV Safety Systems and Operations at Fresenius Medical Care North America and as the Associate Director of Safety Systems at Vertex Pharmaceuticals. An advocate for the use of technology in pharmacovigilance, Anand has been at the forefront of implementing cutting-edge systems to enhance efficiency across all aspects of the field. He strongly emphasizes the importance of an integrated ecosystem for seamless information flow between case processing, signal detection, literature search, and submission systems. Anand was honored with the "All Star Award" for Innovation at the Breakthrough 2022 conference held in Boston in Oct 2022. He was also a speaker on practical implementation of AI in PV at the WDSC held in Boston in Oct 2023.